Zhongshan Hospital, Fudan University — Shanghai, Shanghai Municipality

Public research footprint of Zhongshan Hospital, Fudan University, compiled from the ClinicalTrials.gov public registry.

733

Registered studies

315

Active

197

Recruiting now

205

Completed

Stopped or withdrawn

Most-studied conditions

Colorectal Cancer · Metastatic Non-small Cell Lung Cancer With MTAP Deletion · Atherosclerotic Cardiovascular Disease (ASCVD) · Overweight or Obesity

Recently updated registry entries

NCT07638683 — A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With… (Recruiting)
NCT06760052 — Longitudinal Data Registry of Plasma Cell Dyscrasia (Recruiting)
NCT07419295 — A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Zhongshan Hospital, Fudan University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.